Detalhe da pesquisa
1.
Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
Circulation
; 144(22): 1738-1746, 2021 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34649459
2.
Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale: Results From RE-SPECT ESUS.
Stroke
; 52(3): 1065-1068, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33504190
3.
Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups.
Stroke
; 51(6): 1758-1765, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32404035
4.
[Switching to vitamin K antagonists. More strokes during the first week?]. / Umstellung auf Vitamin-K-Antagonisten. Mehr Schlaganfälle in der ersten Woche?
MMW Fortschr Med
; 156(3): 25, 2014 Feb 20.
Artigo
em Alemão
| MEDLINE | ID: mdl-24938053
5.
Atrial fibrillation patient preferences for oral anticoagulation and stroke knowledge: Results of a conjoint analysis.
Clin Cardiol
; 41(6): 855-861, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29696664
6.
Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey.
TH Open
; 2(3): e233-e241, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31249947